Clinical Trial Update: F-18 PSMA for Localization of Parathyroid Adenoma

View source ↗

Summary

A clinical trial evaluating F-18 PSMA as a localization aid for parathyroid adenomas in hyperparathyroidism has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• F-18 PSMA (Fluorine-18 labeled PSMA radiotracer)

Snippet

Sponsor: Emory University | Conditions: Hyperparathyroidism | Status: TERMINATED